For Insights & Analytics

Every function needs a different answer. All of it lands on your team.

Brand wants a persistence read, access wants an exclusion model, medical wants a pathway map, and each needs its own cohort logic. We run the analyses your queue can’t reach — on your definitions, tested against subgroups before they arrive, delivered with limits stated — and the exploratory pass you’d run if you had the time: the growth pocket nobody has asked about yet. It reports to you. You present it.

One example, from our published research

7.5 pts

persistence gap between the two largest specialty pharmacies, same drug classes, same payer type.

Cohorts matched on line of therapy and comorbidity. The gap held across EGFR and ALK inhibitors and every age band. The top pharmacy gets refills out eight days earlier.

NSCLC Specialty Pharmacy ComparisonOncology · January 2026

In practice

What you’re up against

  • The queue is full before the quarter starts.

    Every function needs its own cut. The exploratory pass is the work that would find the next growth pocket, and it’s the work that never gets scheduled.

  • A number without robustness checks comes back to you.

    A headline figure with no matched cohorts, no sensitivity analysis, and no stated limits can’t go in front of leadership. Every number we hand over arrives with the checks already run behind it.

  • An outside number that doesn’t reconcile is a problem.

    Two teams reaching different numbers from the same warehouse is already your week. A third number, built on someone else’s definitions, adds to it.

Our answer

What we do about it

The answer is never just the headline. Every finding comes with the mechanism behind it, how it has moved over recent quarters, the confounders we tested and ruled out, and an explicit account of what the data cannot tell you.

  • 01

    Your definitions, not ours

    Cohort logic, line-of-therapy rules, competitor sets, and business rules come from you. The output reconciles with what you already report.

  • 02

    Sensitivity by default

    Stratified and tested against the obvious alternative explanations before it reaches you: matched cohorts, replication across drug classes and age bands.

  • 03

    The exploratory pass

    A scan across your market for what’s moving that nobody requested. Yours to bring to the brand team.

  • 04

    Limits stated, nothing to administer

    What claims can’t see is written into every deliverable. No pipelines, no seat licences, no second source of truth.

Example analyses

  • Cohort-matched benchmarks
  • Sensitivity and robustness on an existing finding
  • Exploratory market scan
  • Intervention sizing
  • Surge capacity on the request queue

A sample. If it’s in claims, it’s in scope.

The output is not a metric. It is a working understanding of your market — the kind you would otherwise assemble by hand, months after it had already shifted again — and a short, ordered list of where your attention should go first.

What we do

Two ways to work with us.

Most analytics, human or AI, spend their attention on the question you bring. One question, one answer. The finding that changes a quarter usually sits between hundreds of cross-tabs no one thought to triangulate.

Researcher

Bring a question.

Your consultant in a pocket. One brand or access question. The defensible answer in five business days, with the mechanism and the accounts behind it.

  • Where pull-through breaks after a coverage win — the specialty pharmacy, the practice, the prescriber.
  • Whether growth is coming from new writers or deeper adoption in existing practices.
  • Which accounts a competitor's launch will take first, based on who moved last time.
  • Where patients go when they leave your brand and why.
  • Whether a rebate moved share, or paid for control the payer didn't have.
  • Who actually changed after a campaign, not just who was reached.

Sonar

Watches what you aren't.

Every brand team tracks a set of numbers. Sonar goes after what sits between them.

  • Monthly or quarterly, it runs across the dimensions your team tracks and the ones nobody set up a report for, and tells you what changed.
  • A growth pocket no one is calling on. Prescribers starting to slip while it's still recoverable. A gross-to-net driver moving a quarter before reconciliation shows it.
  • It knows the numbers you already watch, so a readout explains what moved underneath them rather than restating them.
  • Each readout: what moved, the reason behind it, and — as applicable — the accounts driving it with a profile on each, specific enough to act on with minimal resources.

What you receive

Researcher or Sonar, every project ends with the same five things.

  1. 1

    An online report. The full finding and every cut behind it.

  2. 2

    An assistant on the report that answers follow-up questions on your own time.

  3. 3

    The entities behind the finding. HCPs, accounts, specialty pharmacies, infusion centers, payers — as applicable to the finding — each with a behavioral profile, exportable to your CRM. The outsized drivers, not a spreadsheet no one reads.

  4. 4

    A live readout with your account strategy partner — the Flyway analyst who conducted the run and audited the results — and the same partner for follow-ups.

  5. 5

    A deck you can forward: the finding, the mechanism, and any accounts behind it, ready for a leadership meeting.

What do you want to change next quarter?

Tell us the change. We'll tell you how we'd go about it, and whether the data can support it.

Learn more